Abstract
Drug metabolism is a general phenomenon which is essential in order to remove foreign compounds from the body. Although the liver is the major organ which metabolizes systemically applied drugs, it has become evident that extrahepatic tissues contain drug-metabolizing enzymes. Various aspects of the metabolism of xenobiotics in the skin have been reviewed (Wattenberg and Leong 1971; Wiebel and Gelboin 1977; Pannatier et al. 1978; Bickers and Kappas 1980; Noonan and Wester 1983; Bickers 1983; Vermorken et al. 1985; Bickers et al. 1986; Goerz and Merk 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akin FJ, Norred WP (1976) Factors affecting measurement of aryl hydrocarbon hydroxylase activity in mouse skin. J Invest Dermatol 67:709–712
Akin FJ, Chamberlain WJ, Chortyk OT (1975) Mouse skin tumorigenesis and induction of aryl hydrocarbon hydroxylase by tobacco smoke fraction. J Natl Cancer Inst 54:907–912
Alexandrov K, Becker M, Frayssinet C, Dubowska W, Guerry R (1982) Persistence of ben-zo[a]pyrenediolepoxide DNA adduct in mouse skin. Cancer Lett 16:247–251
Alvares AP, Kappas A, Levin W, Conney AH (1973) Inducibility of benzo[a]pyrene hydroxylase in human skin by polycyclic hydrocarbons. Clin Pharmacol Ther 14:30–40
Alvares AP, Bickers DR, Kappas A (1974) Induction of drug-metabolizing enzymes and aryl hydrocarbon hydroxylase by microscope immersion oil. Life Sci 14:853–860
Anders MW (1985) Bioactivation of foreign compounds. Academic, Orlando
Ashurst SW, Cohen GM (1981 a) In vivo formation of benzo[a]pyrenediolepoxide-deoxy-adenosine adducts in the skin of mice susceptible to benzo[a]pyrene-induced carcinogenesis. Int J Cancer 27:357–364
Ashurst SW, Cohen GM (1981 b) The formation and persistence of benzo[a]pyrene metabolite-deoxyribonucleoside adducts in rat skin in vivo. Int J Cancer 28:387–392
Ashurst SW, Cohen GM (1982) The formation of benzo[a]pyrene-deoxyribonucleoside adducts in vivo and in vitro. Carcinogenesis 3:267–273
Ashurst SW, Cohen GM, Nesnow S, DiGiovanni J, Slaga TJ (1983) Formation of benzo-[a]pyrene/DNA adducts and their relationship to tumor initiation in mouse epidermis. Cancer Res 43:1024–1029
Asokan P, Das M, Rosenkranz HS, Bickers DR, Mukhtar H (1985) Topically applied ni-tropyrenes are potent inducers of cutaneous and hepatic monooxygenases. Biochem Biophys Res Commun 129:134–140
Asokan P, Das M, Bik DP, Howard PC, McCoy GD, Rosenkranz HS, Bickers DR, Mukhtar H (1986) Comparative effects of topically applied nitrated arenes and their nonnitrated parent arenes on cutaneous and hepatic drug and carcinogen metabolism in neonatal rats. Toxicol Appl Pharmacol 86:33–43
Baars AJ, Mukhtar H, Zoetemelk CEM, Jansen M, Breimer DD (1981) Glutathione-S-transferase activity in rat and human tissues and organs. Comp Biochem Physiol [C]70:285–288
Baer-Dubowska W, Alexandrov K (1981) The binding of benzo[a]pyrene to mouse and rat skin DNA. Cancer Lett 13:47–52
Baron J, Kawabata TT, Redick JA, Knapp SA, Wick DG, Wallace RB, Jakoby WB, Guengerich FP (1983) Localization of carcinogen-metabolizing enzymes in human and animal tissues. In: Rydström J, Montelius J, Bengtsson M (eds) Extrahepatic drug metabolism and chemical carcinogenesis. Elsevier, Amsterdam, pp 73–88
Baron J, Voigt JM, Whitter TB, Kawabata TT, Knapp SA, Guengerich FP, Jakoby WB (1986) Identification of intratissue sites for xenobiotic activation and detoxication. In: Kocsis JJ, Jollow DJ, Witmer CM, Nelson JO, Snyder R (eds) Biological reactive intermediates. III. Mechanisms of action in animal models and human disease. Plenum, New York, pp 119–144
Benedict WF, Considine N, Nebert DW (1973) Genetic differences in aryl hydrocarbon hydroxylase induction and benzo[a]pyrene-produced tumorigenesis in the mouse. Mol Pharmacol 9:266–277
Berry DL, Bracken WR, Slaga TJ (1977) Benzo[a]pyrene metabolism in mouse epidermis: analysis by high pressure liquid chromatography and DNA binding. Chem Biol Interact 18:129–142
Bickers DR (1983) Drug, carcinogen and steroid hormone metabolism in the skin. In: Goldsmith LA (ed) Biochemistry and physiology of the skin. Oxford University Press, New York, pp 1169–1186
Bickers DR, Kappas A (1978) Human skin aryl hydrocarbon hydroxylase — induction by coal tar. J Clin Invest 62:1061–1068
Bickers DR, Kappas A (1980) The skin as a site of chemical metabolism. In: Gram TE, Vessel E, Garattini S (eds) Extrahepatic metabolism of drugs and foreign compounds. Spectrum, Jamaica, pp 295–318 (Monographs in pharmacology and physiology, vol V)
Bickers DR, Kappas A, Alvares AP (1974) Differences in inducibility of cutaneous and hepatic drug metabolizing enzymes and cytochrome P-450 by polychlorinated biphenyls and 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT). J Pharmacol Exp Ther 188:300–309
Bickers DR, Eiseman J, Kappas A, Alvares AP (1975) Microscope immersion oils: effects of skin application on cutaneous and hepatic drug metabolizing enzymes. Biochem Pharmacol 24:779–783
Bickers DR, Dixit R, Mukhtar H (1982 a) Hematoporphyrin photosensitization of epidermal microsomes results in destruction of cytochrome P-450 and in decreased monoxy-genase activities and heme content. Biochem Biophys Res Commun 108:1032–1039
Bickers DR, Dutta-Choudhury T, Mukhtar H (1982 b) Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity. Mol Pharmacol 21:239–247
Bickers DR, Marcelo L, Dutta-Choudhury T, Mukhtar H (1982 c) Studies on microsomal cytochrome P-450 monooxygenases and epoxide hydrolase in cultured keratinocytes and intact epidermis from BALB/c mice. J Pharmacol Exp Ther 223:163–168
Bickers DR, Mukhtar H, Molica SJ, Pathak MA (1982 d) The effect of psoralens on hepatic and cutaneous drug metabolizing enzymes and cytochrome P-450. J Invest Dermatol 79:201–205
Bickers DR, Wroblewski D, Dutta-Choudhury T, Mukhtar H (1982 e) Induction of neonatal rat skin and liver aryl hydrocarbon hydroxylase by coal tar and its constituents. J Invest Dermatol 78:227–229
Bickers DR, Mukhtar H, Yang SK (1983) Cutaneous metabolism of benzo[a]pyrene: comparative studies in C57BL/6N and DBA/2N mice and neonatal Sprague-Dawley rats. Chem Biol Interact 43:263–270
Bickers DR, Mukhtar H, Dutta-Choudhury T, Marcello CL, Voorhees JJ (1984) Aryl hydrocarbon hydroxylase, epoxide hydrolase, and benzo[a]pyrene metabolism in human epidermis: comparative studies in normal subjects and patients with psoriasis. J Invest Dermatol 83:51–56
Bickers DR, Das M, Mukhtar H (1986) Pharmacological modification of epidermal detoxification systems. Br J Dermatol 115(Suppl 31):9–16
Bigger CAH, Tomaszewski JE, Dipple A (1978) Differences between products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin and in a rat liver microsomal system. Biochem Biophys Res Commun 80:229–235
Bigger CAH, Sawicki JT, Blake DM, Raymond LG, Dipple A (1983) Products of binding of 7,12-dimethylbenz[a]anthracene to DNA in mouse skin. Cancer Res 43:5647–5651
Bock KW, von Clausbruch UC, Kaufmann R, Lilienblum W, Oesch F, Pfeil H, Platt KL (1980) Functional heterogeneity of UDP-glucuronyltransferase in rat tissues. Biochem Pharmacol 29:495–500
Bock KW, Lilienblum W, Pfeil H (1982) Functional heterogeneity of UDP-glucuronosyl-transferase activities in C57BL/6 and DBA/2 mice. Biochem Pharmacol 31:1273–1277
Bock KW, Burchell B, Dutton GJ, Hänninen O, Mulder GJ, Owens IS, Siest G, Tephly TR (1983) UDP-glucuronosyltransferase activities. Biochem Pharmacol 32:953–955
Bowden GT, Slaga TJ, Shapas BG, Boutwell RK (1974) The role of aryl hydrocarbon hydroxylase in skin tumor initiation by 7,12-dimethylbenz[a]anthracene and 1,2,5,6-dibenzanthracene using DNA binding and thymidine-3H incorporation into DNA as criteria Cancer Res 34:2634–2642
Bresnick E, McDonald TF, Yagi H, Jerina DM, Levin W, Wood AW, Conney AH (1977) Epidermal hyperplasia after topical application of benzo[a]pyrene, benzo[a]pyrene diol epoxides and other metabolites. Cancer Res 37:984–990
Briggs MM; Briggs M (1973) Induction by topical corticosteroids of skin enzymes metabolizing carcinogenic hydrocarbons. Br J Dermatol 88:75–81
Brookes P (1979) The binding to mouse skin DNA of benzo[a]pyrene, its 7,8-diol and 7,8-diol-9,10-epoxides in relation to the tumorigenicity of these compounds. Cancer Lett 6:285–289
Brookes P, Duncan ME (1971) Carcinogenic hydrocarbons and human cells in culture. Nature 234:40–43
Buening MK, Levin W, Wood AW, Chang RL, Lehr RE, Taylor CW, Yagi H, Jerina DM, Conney AH (1980) Tumorigenic activity of benzo[e]pyrene derivatives on mouse skin and newborn mice. Cancer Res 40:203–206
Bürki K, Liebelt AG, Bresnick E (1973) Induction of aryl hydrocarbon hydroxylase in mouse tissues from a high and low cancer strain and their F1 hybrids. J Natl Cancer Inst 50:369–380
Bürki K, Stoming TA, Bresnick E (1974) Effects of an epoxide hydrase inhibitor on in vitro binding of polycyclic hydrocarbons to DNA and on skin carcinogenesis. J Natl Cancer Inst 52:785–788
Bundgaard H, Hoelgaard A, Møllgaard B (1983) Leaching of hydrolytic enzymes from human skin in cutaneous permeation studies as determined with metronidazole and 5-fluorouracil pro-dugs. Int J Pharm (Amst) 15:285–292
Caldwell J, Jakoby WB (1983) Biological basis of detoxication. Academic, New York
Camus AM, Pyerin WG, Grover PL, Sims P, Malaveille C, Bartsch H (1980) Mutagenicity of benzo[a]pyrene 7,8-dihydrodiol and 7,12-dimethylbenz[a]anthracene 3,4-dihydro-diol in S. typhimurium mediated by microsomes from rat liver and mouse skin. Chem Biol Interact 32:257–265
Cavalieri EL, Rogan EG (1984) One-electron and two-electron oxidation in aromatic hydrocarbon carcinogenesis. In: Pryor WA (ed) Free radicals in biology, vol VI. Academic, Orlando, pp 323–369
Chan PC, Okamoto T, Wynder EL (1972) The possible role of riboflavin deficiency in epithelial neoplasia. III. Induction of microsomal aryl hydrocarbon hydroxylase. J Natl Cancer Inst 48:1341–1345
Chang RL, Levin W, Wood AW, Lehr RE, Kumar S, Yagi H, Jerina DM, Conney AH (1982) Tumorigenicity of bay-region diol-epoxides and other benzo-ring derivatives of dibenzo[a,h]pyrene and dibenzo[a,i]pyrene in mouse skin and in newborn mice. Cancer Res 42:25–29
Chang RL, Levin W, Wood AW, Yagi H, Tada M, Vyas KP, Jerina DM, Conney AH (1983) Tumorigenicity of enantiomers of chrysene 1,2-dihydrodiol and of the diastereomeric bay-region chrysene l,2-diol-3,4-epoxides on mouse skin and in newborn mice. Cancer Res 43:192–196
Cheung YW, Po ALW, Irvin WJ (1985) Cutaneous biotransformation as a parameter in the modulation of the activity of topical corticosteroids. Int J Pharm (Amst) 26:175–189
Chouroulinkov I, Gentil A, Grover PL, Sims P (1976) Tumour-initiating activities on mouse skin of dihydrodiols derived from benzo[a]pyrene. Br J Cancer 34:523–532
Chouroulinkov I, Gentil A, Tierney B, Grover PL, Sims P (1977) The metabolic activation of 7-methylbenz[a]anthracene in mouse skin: high tumour-initiating activity of the 3,4-dihydrodiol. Cancer Lett 3:247–253
Chouroulinkov I, Gentil A, Tierney B, Grover PL, Sims P (1979 a) Biological activities of dihydrodiols derived from two polycyclic hydrocarbons in rodent test systems. Br J Cancer 39:376–382
Chouroulinkov I, Gentil A, Tierney B, Grover PL, Sims P (1979 b) The initiation of tumors on mouse skin by dihydrodiols derived from 7,12-dimethylbenz[a]anthracene and 3-methylcholanthrene. Int J Cancer 24:455–460
Chuang AHL, Mukhtar H, Bresnick E (1978) Effects of diethyl maleate on aryl hydrocarbon hydroxylase and on 3-methylcholanthrene-induced skin tumorigenesis in rats and mice. J Natl Cancer Inst 60:321–325
Cohen GM, Bracken WM, Iyer RP, Berry DL, Selkirk JK, Slaga TJ (1979) Anticarcino-genic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene tumor initiation and its relationship to DNA binding. Cancer Res 39:4027–4033
Conney AH (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons. Cancer Res 42:4875–4917
Coomes MW, Norling AH, Pohl RJ, Müller D, Fouts JR (1983) Foreign compound metabolism by isolated skin cells from the hairless mouse. J Pharmacol Exp Ther 225:770–777
Coomes MW, Sparks RW, Fouts JR (1984) Oxidation of 7-ethoxycoumarin and conjugation of umbelliferone by intact, viable epidermal cells from the hairless mouse. J Invest Dermatol 82:598–601
Cooper CS, Ribeiro O, Hewer A, Walsh C, Pal K, Grover PL, Sims P (1980) The involvement of a “bay-region” and a non-“bay-region” diol-epoxide in the metabolic activation of benz[a]anthracene in mouse skin and in hamster embryo cells. Carcinogenesis 1:233–243
Damen FJM, Mier PD (1982) Cytochrome P-450-dependent-O-dealkylase activity in mammalian skin. Br J Pharmacol 75:123–127
Das M, Bickers DR, Santella RM, Mukhtar H (1985) Altered patterns of cutaneous xeno-biotic metabolism in UVB-induced squamous cell carcinoma in SKH-1 hairless mice. J Invest Dermatol 84:532–536
Das M, Bickers DR, Mukhtar H (1986 a) Epidermis: the major site of cutaneous benzo[a]-pyrene and benzo[a]pyrene 7,8-diol metabolism in neonatal BALB/c mice. Drug Metab Dispos 14:637–642
Das M, Mukhtar H, Del Tito BJ, Marcelo CL, Bickers DR (1986 b) Clotrimazole, an inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulfation, and macromolecular binding in BALB/c mouse cultured keratinocytes. J Invest Dermatol 87:4–10
Das M, Asokan P, Don PSC; Krueger GG, Bickers DR, Mukhtar H (1986 c) Carcinogen metabolism in human skin grafted onto athymic nude mice: a model system for the study of human skin carcinogenesis. Biochem Biophys Res Commun 138:33–39
Daudel P, Duquese M, Vigny P, Grover PL, Sims P (1975) Fluorescene spectral evidence that benzo[a]pyrene-DNA products in mouse skin arise from diol-epoxides. FEBS Lett 57:250–253
Del Tito BJ, Mukhtar H, Bickers DR (1984) In vivo metabolism of topically applied benzo[a]pyrene-4,5-oxide in neonatal rat skin. J Invest Dermatol 82:378–380
DiGiovanni J, Slaga TJ, Berry DL, Juchau MR (1977) Metabolism of 7,12-dimethylbenz-[a]anthracene in mouse skin homogenates analyzed with high-pressure liquid chromatography. Drug Metab Dispos 5:295–301
DiGiovanni J, Viaje A, Fischer S, Slaga TJ, Boutwell RK (1980) Biotransformation of 7,12-dimethylbenz[a]anthracene by mouse epidermal cells in culture. Carcinogenesis 1:41–49
DiGiovanni J, Miller DR, Singer JM; Viaje A, Slaga TJ (1982) Benzo[a]pyrene metabolism in primary cultures of mouse epidermal cells and untransformed epidermal cell lines. Cancer Res 42:2579–2586
DiGiovanni J, Nebzydoski AP, Decina PC (1983 a) Formation of 7-hydroxymethyl-12-methylbenz[a]anthracene-DNA adducts from 7,12-dimethylbenz[a]anthracene in mouse epidermis. Cancer Res 43:4221–4226
DiGiovanni J, Sina JF, Ashurst SW, Singer JM, Diamond L (1983 b) Benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene metabolism and DNA adduct formation in primary cultures of hamster epidermal cells. Cancer Res 43:163–170
DiGiovanni J, Fisher EP, Aalfs KK, Prichett WP (1985) Covalent binding of 7,12-dimethylbenz[a]anthracene and 10-fluoro-7,12-dimethylbenz[a]anthracene to mouse epidermal DNA and its relationship to tumor-initiating activity. Cancer Res 45:591–597
Dutton GJ, Stevenson IH (1962) The stimulation by 3,4-benzpyrene of glucuronide synthesis in the skin. Biochim Biophys Acta 58:633–634
Eling T, Curtis J, Battista J, Marnett LJ (1986) Oxidation of (+)-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by mouse keratinocytes: evidence for peroxyl radical- and mono-xygenase-dependent metabolism. Carcinogenesis 7:1957–1963
Finnen MJ, Shuster S (1985) Phase 1 and phase 2 drug metabolism in isolated epidermal cells from adult hairless mice and in whole human hair follicles. Biochem Pharmacol 34:3571–3575
Finnen MJ, Shuster S, Lawrence CM, Rawlins MD (1983) Aryl hydrocarbon hydroxylase activity and psoriasis. Biochem Pharmacol 32:1707–1711
Finnen MJ, Herdman ML, Shuster S (1984 a) Induction of drug metabolizing enzymes in the skin by topical steroids. J Steroid Biochem 20:1169–1173
Finnen MJ, Lawrence CM, Shuster S (1984 b) Human skin aryl hydrocarbon hydroxylase. Br J Dermatol 110:339–342
Finnen MJ, Herdman ML, Shuster S (1985) Distribution and sub-cellular localization of drug metabolizing enzymes in the skin. Br J Dermatol 113:713–721
Fox HC, Selkirk JK, Price FM, Croy RG, Sanford KK, Cottier-Fox M (1975) Metabolism of benzo[a]pyrene by human epithelial cells in vitro. Cancer Res 35:3551–3557
Gelboin HV (1980) Benzo[a]pyrene metabolism, activation, and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 60:1107–1166
Gelboin HV, Wiebel FJ (1971) Studies on the mechanism of aryl hydrocarbon hydroxylase induction and its role in cytotoxicity and tumorigenicity. Ann NY Acad Sci 179:529–547
Gelboin HV, Wiebel F, Diamond L (1970) Dimethylbenzanthracene tumorigenesis and aryl hydrocarbon hydroxylase in mouse skin: inhibition by 7,8-benzoflavone. Science 170:169–171
Gelboin HV, Kinoshita N, Wiebel FJ (1972) Microsomal hydroxylases: induction and role in polycyclic hydrocarbon carcinogenesis and toxicity. Fed Proc 31:1298–1309
Gielen JE, Goujon FM, Nebert DW (1972) Genetic regulation of aryl hydrocarbon hydroxylase induction. II. Simple Mendelian expression in mouse tissue in vivo. J Biol Chem 247:1125–1137
Goerz G, Merk H (1987) Animal models for cutaneous drug-metabolizing enzymes. In: Maibach HI, Lowe NJ (eds) Models in dermatology, vol III. Karger, Basel, pp 93–105
Goerz G, Berger H, Tsambaos D (1981) A new animal model for the study of cutaneous drug-metabolizing enzymes. Arch Dermatol Res 270:367–369
Goerz G, Merk H, Bolsen K, Tsambaos D, Berger H (1983) Influence of chronic UV-light exposure on hepatic and cutaneous monoxygenases. Experientia 39:385–386
Gomez EC, Michaelover J, Frost P (1977) Cutaneous β-glucuronidase: cleavage of mycophenolic acid by preparations of mouse skin. Br J Dermatol 97:303–306
Gram TE, Vessel E, Garattini S (1980) Extrahepatic metabolism of drugs and foreign compounds. Spectrum, Jamaica New York (Monographs in pharmacology and physiology, vol V)
Grover PL, Hewer A, Pal K, Sims P (1976) The involvement of a diol-epoxide in the metabolic activation of benzo[a]pyrene in human bronchial mucosa and in mouse skin. Int J Cancer 18:1–6
Harper KH, Calcutt G (1960) Conjugation of 3,4-benzpyrenols in mouse skin. Nature 186:80–81
Hecht SS, Rivenson A, Hoffmann D (1980) Tumor-initiating activity of dihydrodiols formed metabolically from 5-methylchrysene. Cancer Res 40:1396–1399
Heimann R, Rice RH (1983) Polycyclic aromatic hydrocarbon toxicity and induction of metabolism in cultivated esophageal and epidermal keratinocytes. Cancer Res 43:4856–4862
Herz-Hübner U, Täuber U (1977) Metabolisierung von Fluocortin-butylester in der Haut von Meerschweinchen und Mensch. Arzneim Forsch 27:2226–2229
Hosomi J, Nemeto N, Kuroki T (1982) Metabolism of benzo[a]pyrene and other carcinogens in mouse epidermal keratinocytes in culture. Gann 73:879–886
Hosomi J, Nemeto N, Kuroki T (1983) Genetic differences in metabolism of benzo[a]-pyrene in cultured epidermal and dermal cells of responsive and nonresponsive mice. Cancer Res 43:3643–3648
Huberman E, Sachs L (1973) Metabolism of the carcinogenic hydrocarbon benzo[a]pyrene in human fibroblast and epithelial cells. Int J Cancer 11:412–418
Hudson LG, Shaikh R, Toscano WA, Greenlee WF (1983) Induction of 7-ethoxycoumarin O-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. Biochem Biophys Res Commun 115:611–617
Hukkelhoven MWAC, Irmscher G, Fusenig NE (1980) Metabolism of 7,12-dimethylbenz-anthracene (DMBA) by mouse skin keratinocytes, fibroblasts, and carcinoma cells in culture. Arch Toxicol 44:181–195
Hukkelhoven MWAC, Vromans E, Vermorken AJM, Bleomendal H (1981) Enzyme induction in cultured human hair follicle cells. Mol Biol Rep 8:25–28
Hukkelhoven MWAC, Vromans E, Vermorken AJM, Bloemendal H (1982 a) Formation of dihydrodiol metabolites of benzo[a]pyrene in cultured human and murine skin cells. Anticancer Res 2:89–94
Hukkelhoven MWAC, Vromans EWM, Vermorken AJM, Bloemendal H (1982 b) A sensitive fluorometric assay for epoxide hydratase. FEBS Lett 144:104–108
Hukkelhoven MWAC, Dijkstra AC, Vermorken AJM (1983 a) Rapid high-performance liquid chromatographic method for detection of interindividual differences in carcinogen metabolism. J Chromatogr 276:189–196
Hukkelhoven MWAC; Dijkstra AC, Vermorken AJM (1983 b) Human hair follicles and cultured hair follicle keratinocytes as indicators for individual differences in carcinogen metabolism. Arch Toxicol 53:265–274
Hukkelhoven MWAC; Vromans LWM, van Pelt FNAM, Keulers RAC, Vermorken AJM (1984) In vivo induction of aryl hydrocarbon hydroxylase in human scalp hair follicles by topical application of a commercial coal tar preparation. Cancer Lett 23:135–143
Hukkelhoven MWAC, Bronkhorst AM, Vermorken AJM (1985) Covalent binding of BP-metabolites to DNA of cultured human hair follicle keratinocytes. Arch Toxicol 57:6–12
Irmscher G, Fusenig NE (1980) Metabolism of 7,12-dimethylbenzanthracene (DMBA) by mouse skin keratinocytes, fibroblasts, and carcinoma cells in culture. Arch Toxicol 44:181–195
Iversen OH, Digernes V (1981) Increased epidermal DT-diaphorase activity induced by some carcinogens. Virchows Arch [B] 36:133–138
Jakoby WB (1980) Enzymatic basis of detoxication, vol I, II. Academic, New York
Jakoby WB, Bend JR, Caldwell J (1982) Metabolic basis of detoxication — metabolism of functional groups. Academic, New York
Juchau MR, Namkung MJ, Berry DL, Zachariah PK (1975) Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys — correlations with aryl hydrocarbon hydroxylase activities. Drug Metab Dispos 3:494–501
Kaneko M, Cerutti PA (1982) Excision of benzo[a]pyrene diol epoxide I adducts from nu-cleosomal DNA of confluent normal human fibroblasts. Chem Biol Interact 38:261–274
Kao J, Hall J, Shugart LR, Holland JM (1984) An in vitro approach to studying cutaneous metabolism and disposition of topically applied xenobiotics. Toxicol Appl Pharmacol 75:289–298
Kao J, Patterson FJ, Hall J (1985) Skin penetration and metabolism of topically applied chemicals in six mammalian species including man: an in vitro study with benzo[a]-pyrene and testosterone. Toxicol Appl Pharmacol 81:502–516
Kinoshita N, Gelboin HV (1972) The role of aryl hydrocarbon hydroxylase in 7,12-dimeth-ylbenz[a]anthracene skin tumorigenesis: on the mechanism of 7,8-benzoflavone inhibition of tumorigenesis. Cancer Res 32:1329–1339
Koreeda M, Moore PD, Wislocki PG, Levin W, Conney AH, Yagi H, Jerina DM (1978) Binding of benzo[a]pyrene 7,8-diol-9,10-epoxides to DNA, RNA, and protein of mouse skin occurs with high stereoselectivity. Science 199:778–781
Krauss RS, Eling TE (1984) Arachidonic acid-dependent cooxidation. Biochem Pharmacol 33:3319–3324
Kumar S, Antony M, Mehrotra NK (1982) Induction of benzo[a]pyrene hydroxylase in skin and liver by cutaneous application of jute batching oil. Toxicology 23:347–352
Kuroki T, Nemoto N, Kitano Y (1980) Metabolism of benzo[a]pyrene in human epidermal keratinocytes in culture. Carcinogenesis 1:559–565
Kuroki T, Hosomi J, Nemoto N (1981) Variation in metabolism of benzo[a]pyrene in epidermal keratinocytes and dermal fibroblasts of humans and mice. Gann Monogr 27:59–71
Kuroki T, Hosomi J, Munakata K, Onizuka T, Terauchi M, Nemoto N (1982) Metabolism of benzo[a]pyrene in epidermal keratinocytes and dermal fibroblasts of human and mice with reference to variation among species, individuals, and cell types. Cancer Res 42:1859–1865
Laaksonen AM, Mäntyjärvi RA, Hänninen OOP (1983) Fibroblast cultures of nude mouse skin as targets for transformation by chemical carcinogens. Med Biol 61:59–64
Lawrence CM, Finnen MJ, Shuster S (1984) Effect of coal tar on cutaneous aryl hydrocarbon hydroxylase induction and anthralin irritancy. Br J Dermatol 110:671–675
Legraverend C, Mansour B, Nebert DW, Holland JM (1980) Genetic differences in benzo[a]pyrene-initiated tumorigenesis in mouse skin. Pharmacology 20:242–255
Lesca P (1983) Modulating effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on skin carcinogenesis initiated by 7,12-dimethylbenz[a]anthracene in CF-1 Swiss mice. In: Rydström J, Montelius J, Bengtsson M (eds) Extrahepatic drug metabolism and chemical carcinogenesis. Elsevier, Amsterdam, pp 589–590
Levin W, Wood AW, Yagi H, Dansette PM, Jerina DM, Conney AH (1976 a) Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skin. Proc Natl Acad Sci USA 73:243–247
Levin W, Wood AW, Yagi H, Jerina DM, Conney AH (1976 b) (+)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene: a potent skin carcinogen when applied topically to mice. Proc Natl Acad Sci USA 73:3867–3871
Levin W, Wood AW, Chang RL, Slaga TJ, Yagi H, Jerina DM, Conney AH (1977 a) Marked differnces in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene on mouse skin. Cancer Res 37:2721–2725
Levin W, Wood AW, Wislocki PG, Kapitulnik J, Yagi H, Jerina DM, Conney AH (1977 b) Carcinogenicity of benzo-ring-derivatives of benzo[a]pyrene on mouse skin. Cancer Res 37:3356–3361
Levin W, Thakker DR, Wood AW, Chang RL, Lehr RE, Jerina DM, Conney AH (1978 a) Evidence that benzo[a]anthracene 3,4-diol-1,2-epoxide is an ultimate carcinogen on mouse skin. Cancer Res 38:1705–1710
Levin W, Wood AW, Chang RL, Yagi H, Mah HD, Jerina DM, Conney AH (1978 b) Evidence for bay region activation of chrysene 1,2-dihydrodiol to an ultimate carcinogen. Cancer Res 38:1831–1834
Levin W, Buening MK, Wood AW, Chang RL, Thakker DR, Jerina DM, Conney AH (1979) Tumorigenic activity of 3-methylcholanthrene metabolites on mouse skin and in newborn mice. Cancer Res 39:3549–3553
Levin W, Buening MK, Wood AW, Chang RL, Kedzierski B, Thakker DR, Boyd DR, Gadaginamath GS, Armstrong RN, Yagi H, Karle JM, Slaga TJ, Jerina DM, Conney AH (1980 a) An enantiomeric interaction in the metabolism and tumorigenicity of (+)- and (-)-benzo[a]pyrene 7,8-oxide. J Biol Chem 255:9067–9074
Levin W, Wood AW, Chang RL, Ittah Y, Croisy-Delcey M, Yagi H, Jerina DM, Conney AH (1980 b) Exceptionally high tumor-initiating activity of benzo[c]phenanthrene bay-region diol-epoxides in mouse skin. Cancer Res 40:3910–3914
Lilienblum W, Irmscher G, Fusenig NE, Bock KW (1986) Induction of UDP-glucuronyl-transferase and arylhydrocarbon hydroxylase activity on mouse skin and in normal and transformed skin cells in culture. Biochem Pharmacol 35:1517–1520
Loftsson T, Bodor N (1981) Improved delivery through biological membranes X: percutaneous absorption and metabolism of methylsulfinylmethyl 2-acetoxybenzoate and related aspirin prodrugs. J Pharm Sci 70:756–758
MacNicoll AD, Grover PL, Sims P (1980) The metabolism of a series of polycyclic hydrocarbons by mouse skin maintained in short-term organ culture. Chem Biol Interact 29:169–188
Manil L, van Cantfort J, Lapiere CM, Gielen JE (1981) Significant variation in mouse-skin aryl hydrocarbon hydroxylase inducibility as a function of the hair growth cycle. Br J Cancer 43:210–221
Melikian AA, La Voie EJ, Hecht SS, Hoffmann D (1982) Influence of a bay-region methyl group on formation of 5-methylchrysene dihydrodiol epoxide: DNA adducts in mouse skin. Cancer Res 42:1239–1242
Melikian AA, La Voie EJ, Hecht SS, Hoffmann D (1983) 5-Methylchrysene metabolism in mouse epidermis in vivo, diol epoxide-DNA adduct persistence, and diol epoxide reactivity with DNA as potential factors influencing the predominance of 5-meth-ylchrysene-l,2-diol-3,4-epoxide-DNA adducts in mouse epidermis. Carcinogenesis 4:843–849
Melikian AA, Leszczynska JM, Hecht SS, Hoffmann D (1986) Effects of the co-carcinogen catechol on benzo[a]pyrene metabolism and DNA adduct formation in mouse skin. Carcinogenesis 7:9–15
Merk H, Rumpf M, Bolsen K, Wirth G, Goerz G (1984) Inducibility of arylhydrocarbon-hydroxylase activity in human hair follicles by topical application of liquor carbonis detergens (coal tar). Br J Dermatol 111:279–284
Mier PD, van den Hurk JJMA (1975) Lysosomal hydrolases of the epidermis. I. Glycosi-dases. Br J Dermatol 93:1–10
Møllgaard B, Hoelgaard A, Bundgaard H (1982) Pro-drugs as drug delivery systems XXIII. Improved dermal delivery of 5-fluorouracil through human skin via N-acyloxy-methyl pro-drug derivatives. Int J Pharm (Amst) 12:153–162
Moloney SJ, Bridges JW, Fromson JM (1982 a) UDP-glucuronosyltransferase activity in rat- and hairless mouse skin-microsomes. Xenobiotica 12:481–487
Moloney SJ, Fromson JM, Bridges JW (1982 b) The metabolism of 7-ethoxycoumarin and 7-hydroxycoumarin by rat and hairless mouse skin strips. Biochem Pharmacol 31:4005–4009
Moloney SJ, Fromson JM, Bridges JW (1982 c) Cytochrome P-450 dependent deethylase activity in rat and hairless mouse skin microsomes. Biochem Pharmacol 31:4011–4018
Mukhtar H, Bickers DR (1981 a) Comparative activity of the mixed-function oxidases, epoxide hydratase, and glutathione-S-transferase in liver and skin of the neonatal rat. Drug Metab Dispos 9:311–314
Mukhtar H, Bickers DR (1981b) Aminopyrine-N-demethylase activity in neonatal rat skin. Biochem Pharmacol 30:3257–3260
Mukhtar H, Bickers DR (1982) Evidence that coal tar is a mixed inducer of microsomal drug-metabolizing enzymes. Toxicol Lett 11:221–227
Mukhtar H, Bickers DR (1983) Age-related changes in benzo[a]pyrene metabolism and ep-oxide-metabolizing enzyme activities in rat skin. Drug Metab Dispos 11:562–567
Mukhtar H, Bresnick E (1976) Glutathione-S-epoxidetransferase in mouse skin and human foreskin. J Invest Dermatol 66:161–164
Mukhtar H, Dixit R, Seth PK (1981) Reduction in cutaneous and hepatic glutathione contents, glutathione-S-transferase and aryl hydrocarbon hydroxylase activities following topical application of acrylamide to mouse. Toxicol Lett 9:153–156
Mukhtar H, Link CM, Cherniack E, Kushiner DM, Bickers DR (1982) Effect of topical application of defined hydroxylase and 7-ethoxycoumarin deethylase activities. Toxicol Appl Pharmacol 64:541–549
Mukhtar H, Del Tito BJ, Marcelo CL, Das M, Bickers DR (1984 a) Ellagic acid: a potent naturally occurring inhibitor of benzo[a]pyrene metabolism and its subsequent glucuronidation, sulfation and covalent binding to DNA in cultured BALB/c mouse keratinocytes. Carcinogenesis 5:1565–1571
Mukhtar H, Del Tito BJ, Das M, Cherniack EP, Cherniack AD, Bickers DR (1984 b) Clotrimazole, an inhibitor of epidermal benzo[a]pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon. Cancer Res 44:4233–4240
Mukhtar H, Das M, Del Tito BJ, Bickers DR (1984 c) Epidermal benzo[a]pyrene metabolism and DNA-binding in BALB/c mice: inhibition by ellagic acid. Xenobiotica 14:527–531
Nakayama J, Yuspa SH, Poirier MC (1984) Benzo[a]pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis. Cancer Res 44:4087–4095
Nebert DW (1979) Genetic differences in the induction of monooxygenase activities by polycyclic aromatic compounds. Pharmacol Ther 6:395–417
Nebert DW, Bausserman LL, Bates RR (1970) Effect of 17β-estradiol and testosterone on aryl hydrocarbon hydroxylase activity in mouse tissues in vivo and in cell culture. Int J Cancer 6:470–480
Nebert DW, Benedict WF, Gielen JE, Oesch F, Daly JW (1972) Aryl hydrocarbon hydroxylase, epoxide hydrase, and 7,12-dimethylbenz[a]anthracene-produced skin tumorigenesis in the mouse. Mol Pharmacol 8:374–379
Noonan PK, Wester RC (1983) Cutaneous biotransformations and some pharmacological and toxicological implications. In: Marzulli FN, Maibach HI (eds) Dermatotoxicology, 2nd edn. Hemisphere, Washington, pp 71–90
Norden G (1953) The role of appearance, metabolism and disappearance of 3,4-benzpyrene in the epithelium of mouse skin. Acta Pathol Microbiol Scand [Suppl]96:1–87
Norred WP, Akin FJ (1976) Induction of aryl hydrocarbon hydroxylase and carbon monoxide binding hemoproteins in mouse epidermis by tobacco carcinogens. Biochem Pharacol 25:732–734
Oesch F, Schmassmann H (1979) Species and organ specificity of the trans-stilbene oxide induced effects on epoxide hydratase and benzo[a]pyrene monoxygenase activity in rodents. Biochem Pharmacol 28:171–176
Oesch F, Glatt H, Schmassmann H (1977) The apparent ubiquity of epoxide hydratase in rat organs. Biochem Pharmacol 26:603–607
Oesch F, Schmassmann H, Bentley P (1978) Specificity of human rat and mouse skin epoxide hydratase towards K-region epoxides of polycyclic hydrocarbons. Biochem Pharmacol 27:17–20
Oesch F, Tegtmeyer F, Kohl F-V, Rüdiger H, Glatt HR (1980) Interindividual comparison of epoxide hydratase and glutathione-S-transferase activities in cultured human fibroblasts. Carcinogenesis 1:305–309
Ohkawara A, Halprin KM, Taylor JR, Levine V (1972) Acid hydrolases in human epidermis. Br J Dermatol 83:450–459
O’Neill VA, Rawlins MD; Chapman PH (1981) Epoxide hydrolase activity in human skin. Br J Clin Pharmacol 12:517–521
Pannatier A, Jenner P, Testa B, Etter JC (1978) The skin as a drug-metabolizing organ. Drug Metab Rev 8:319–343
Pannatier A, Testa B, Etter J-C (1981 a) Aryl ether O-dealkylase activity in the skin of untreated mice in vitro. Xenobiotica 11:345–350
Pannatier A, Testa B, Etter J-C (1981 b) Enzymatic hydrolysis by mouse skin homogenates: structure-metabolism relationships of para-nitrobenzoate esters. Int J Pharm 8:167–174
Pannatier A, Testa B, Etter J-C (1982) Effect of topically applied phenobarbital on O-dealkylase activity in mouse skin. Experientia 38:604–605
Parkinson EK, Newbold RF (1980) Benzo[a]pyrene metabolism and DNA adduct formation in serially cultured strains of human epidermal keratinocytes. Int J Cancer 26:289–299
Pelling JC, Slaga TJ (1982) Comparison of levels of benzo[a]pyrene diol epoxide diaste-reomers covalently bound in vivo to macromolecular components of the whole epidermis versus the basal cell layer. Carcinogenesis 3:1135–1141
Pereira A, Burns FJ, Albert RE (1979) Dose response for benzo[a]pyrene adducts in mouse epidermal DNA. Cancer Res 39:2556–2559
Pohl RJ, Philpot RM, Fouts JR (1976) Cytochrome P-450 content and mixed-function oxidase activity in microsomes isolated from mouse skin. Drug Metab Dispos 4:442–450
Pohl RJ, Coomes MW, Sparks RW, Fouts JR (1984) 7-Ethoxycoumarin O-deethylation activity in viable basal and differentiated keratinocytes isolated from the skin of the hairless mouse. Drug Metab Dispos 12:25–34
Poland AP, Glover E, Robinson JR, Nebert DW (1974) Genetic expression of aryl hydrocarbon hydroxylase activity. J Biol Chem 249:5599–5606
Puhvel SM, Ertl DC (1984) Decreased induction of aryl hydrocarbon hydroxylase activity in hyperproliferative hairless mouse epidermis. Br J Dermatol 110:29–35
Pyerin WG, Hecker E (1975) Epoxide hydrase activity in mouse skin epidermis. Z Krebsforsch 83:81–83
Pyerin WG, Hecker E (1977) On the biochemical mechanism of tumorigenesis in mouse skin. VIII. Isolation and characterization of epidermal microsomes and properties of their arylhydrocarbon monooxygenase and epoxide hydr(at)ase. Z Krebsforsch 90:259–279
Pyerin WG, Hecker E (1979) On the biochemical mechanism of tumorigenesis in mouse skin. IX. Interrelation between tumor initiation by 7,12-dimethylbenz[a]anthracene and the activities of epidermal arylhydrocarbon monooxygenase and epoxide hydra-tase. J Cancer Res Clin Oncol 93:7–30
Pyerin WG, Oberender HA, Hecker E (1980) Extent of skin tumour initiation in mice by 7,12-dimethylbenz[a]anthracene and induction of arylhydrocarbon monooxygenase are not causally related. Cancer Lett 10:155–162
Rahimtula AD, Payne JF, Martins I (1982) Hydrocarbon-based oils as inducers of cutaneous aryl hydrocarbon hydroxylase. Toxicol Lett 10:213–217
Raunio H, Pelkonen O (1982) Independent induction and inhibition of ornithine decarboxylase and aryl hydrocarbon hydroxylase activities in rat epidermis. J Invest Dermatol 79:246–249
Rettie AE, Willliams FM, Rawlins MD (1986 a) Substrate specificity of the mouse skin mixed-function oxidase system. Xenobiotica 16:205–211
Rettie AE, Williams FM, Rawlins MD, Mayers RT, Burke MD (1986 b) Major differences between lung, skin and liver in the microsomal metabolism of homologous series of re-sorufin and coumarin ethers. Biochem Pharmacol 35:3495–3500
Rogan E, Roth P, Katomski P, Benderson J, Cavalieri E (1978) Binding of benzo[a]pyrene at the 1,3,6 positions to nucleic acids in vivo on mouse skin and in vitro with rat liver microsomes and nuclei. Chem Biol Interact 22:35–51
Rogan EG, Hakam A, Cavalieri EL (1983) Structure elucidation of a 6-methylbenzo[a]-pyrene-DNA adduct formed by horseradish peroxidase in vitro and mouse skin in vivo. Chem Biol Interact 47:111–122
Rojas M, Baer-Dubowska W, Alexandrov K (1986) Comparison of benzo[a]pyrene-DNA adduct levels in mouse and rat epidermis and dermis. Cancer Lett 30:35–39
Rüdiger HW, Marxen J, Kohl FV, Melderis H, von Wichert P (1979) Metabolism and formation of DNA adducts of benzo[a]pyrene in human diploid fibroblasts. Cancer Res 39:1083–1088
Rugstad HE, Dybing E (1975) Glucuronidation in cultures of human skin epithelial cells. Eur J Clin Invest 5:133–137
Ruzicka T, Printz M (1984) Arachidonic acid metabolism in skin: a review. Rev Physiol Biochem Pharmacol 100:121–160
Schiede E, Conney AH (1970) Induction of benzo[a]pyrene hydroxylase activity in rat skin. Life Sci 9:1295–1303
Schmassmann HU, Glatt HR, Oesch F (1976) A rapid assay for epoxide hydratase activity with benzo[a]pyrene 4,5-(K-region-)oxide as substrate. Anal Biochem 74:94–104
Selkirk JK, Nikbakht A, Stoner GD (1983) Comparative metabolism and macromolecular binding of benzo[a]pyrene in expiant cultures of human bladder, skin, bronchus and esophagus from eight individuals. Cancer Lett 18:11–20
Shugart L, Kao J (1984) Effect of ellagic and caffeic acids on covalent binding of benzo[a] pyrene to epidermal DNA of mouse skin in organ culture. Int J Biochem 15:571–573
Shugart L, Holland JM, Rahn RO (1983) Dosimetry of PAH skin carcinogenesis: covalent binding of benzo[a]pyrene to mouse epidermal DNA. Carcinogenesis 4:195–198
Sivarajah K, Lasker JM, Elin TE (1981) Prostaglandin synthetase-dependent cooxidation of (±)-benzo[a]pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res 41:1834–1839
Slaga TJ, Viaje A, Berry DL, Bracken W, Buty SG, Scribner JD (1976) Skin tumor initiating ability of benzo[a]pyrene 4,5–7,8- and 7,8-diol-9,10-epoxides and 7,8-diol. Cancer Lett 2:115–122
Slaga TJ, Buty SG, Thompson S, Bracken WM, Viaje A (1977 a) A kinetic study on the in vitro covalent binding of polycyclic hydrocarbons to nucleic acids using epidermal homogenates as the activating system. Cancer Res 37:3126–3131
Slaga TJ, Bracken WM, Viaje A, Levin W, Yagi H, Jerina DM, Conney AH (1977 b) Comparison of the tumor-initiating activities of benzo[a]pyrene arene oxides and diol-epox-ides. Cancer Res 37:4130–4133
Slaga TJ, Thompson S, Berry DL, DiGiovanni J, Juchau MR, Viaje A (1977 c) The effects of benzoflavones on polycyclic hydrocarbon metabolism and skin tumor initiation. Chem Biol Interact 17:297–312
Slaga TJ, Viaje A, Bracken WM, Berry DL, Fischer SM, Miller DR, Leclerc SM (1977 d) Skin-tumor-initiating ability of benzo[a]pyrene-7,8-diol-9,10-epoxide (anti) when applied topically in tetrahydrofuran. Cancer Lett 3:23–30
Slaga TJ, Huberman E, Selkirk JK, Harvey RG, Bracken WM (1978) Carcinogenicity and mutagenicity of benz[a]anthracene diols and diol-epoxides. Cancer Res 38:1699–1704
Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM, Conney AH (1979 a) Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides. Cancer Res 39:67–71
Slaga TJ, Gleason GL, DiGiovanni J, Sukumaran KB, Harvey RG (1979 b) Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz[a]anthracene in mouse skin. Cancer Res 39:1934–1936
Slaga TJ, Huberman E, DiGiovanni J, Gleason G (1979 c) The importace of the “bay region” diol-epoxide in 7,12-dimethylbenz[a]anthracene skin tumor initiation and mutagenesis. Cancer Lett 6:213–220
Smith LH, Holland JM (1981) Interaction between benzo[a]pyrene and mouse skin in organ culture. Toxicology 21:47–57
Summer K-H, Göggelmann W (1980) l-Chloro-2,4-dinitrobenzene depletes glutathione in rat skin and is mutagenic in Salmonella typhimurium. Mutat Res 77:91–93
Täuber U, Toda T (1976) Biotransformation von Diflucortolonvalerianat in der Haut von Ratte, Meerschweinchen und Mensch. Arzneim Forsch 26:1484–1487
Tejwani R, Jeffrey AM, Milo GE (1982) Benzo[a]pyrene diol epoxide DNA adduct formation in transformable and non-transformable human foreskin fibroblast cells in vitro. Carcinogenesis 3:727–732
Thakker DR, Yagi H, Levin W, Wood AW, Conney AH, Jerina DM (1985) Polycyclic aromatic hydrocarbons: metabolic activation to ultimate carcinogens. In: Anders MW (ed) Bioactivation of foreign compounds. Academic, Orlando, pp 177–242
Theall G, Eisinger M, Grunberger D (1981) Metabolism of benzo[a]pyrene and DNA ad-duct formation in cultured human epidermal keratinocytes. Carcinogenesis 2:581–587
Thompson S, Slaga TJ (1976 a) Mouse epidermal aryl hydrocarbon hydroxylase. J Invest Dermatol 66:108–111
Thompson S, Slaga TJ (1976 b) The effects of dexamethasone on mouse skin initiation and aryl hydrocarbon hydroxylase. Eur J Cancer 12:363–370
Tierney B, Hewer A, Walsh C, Grover PL, Sims P (1977) The metabolic activation of 7-methylbenz[a]anthracene in mouse skin. Chem Biol Interact 18:179–193
Tierney B, Hewer A, Rattle H, Grover PL, Sims P (1978) The formation of dihydrodiols by chemical or enzymic oxidation of 3-methylcholanthrene. Chem Biol Interact 23:121–135
Van Cantfort J, Lorand T, Gielen JE, Lapiere CM (1986) Human epidermal blister: a convenient tissue for toxicological and genetic studies of benzo[a]pyrene metabolism. Arch Dermatol Res 278:324–328
Vermorken AJM, Goos CMAA, Roelofs HMJ, Henderson PTH, Bloemendal H (1979) Metabolism of benzo[a]pyrene in isolated human scalp hair follicles. Toxicology 14:109–116
Vermorken AJM, Goos CMAA, Hukkelhoven MWAC, de Bruyn CHMM (1985) Human hair follicles in metabolic studies. In: Maibach HI, Lowe NJ (eds) Models in dermatology, vol II. Karger, Basel, pp 189–208
Vigny P, Ginot YM, Kindts M, Cooper CS, Grover PL, Sims P (1980) Fluorescence spectral evidence that benzo[a]pyrene is activated by metabolism in mouse skin to a diolepoxide and a phenol-epoxide. Carcinogenesis 1:945–950
Vigny P, Kindts M, Cooper CS, Grover PL, Sims P (1981) Fluorescence spectra of nucleoside-hydrocarbon adducts formed in mouse skin treated with 7,12-dimethylbenz[a]anthracene. Carcinogenesis 2:115–119
Vizethum W, Ruzicka T, Goerz G (1980) Inducibility of drug-metabolizing enzymes in the rat skin. Chem Biol Interact 31:215–219
Wang IY, Rasmussen RE, Crocker TT (1974) Metabolism of benzo[a]pyrene by microsomes from tissues of pregnant and fetal hamsters. Life Sci 15:1291–1300
Wattenberg LW, Leong JL (1970) Inhibition of the carcinogenic action of benzo[a]pyrene by flavones. Cancer Res 30:1922–1925
Wattenberg LW, Leong JL (1971) Tissue distribution studies of polycyclic hydrocarbon hydroxylase activity. In: Brodie BB, Gillette JR (eds) Concepts in biochemical pharmacology. Springer, Berlin Heidelberg New York, pp 422–430 (Handbook of pharmacology, vol 28/2)
Weigert F, Calcutt G, Powell AV (1948) The course of the metabolism of benzpyrene in the skin of the mouse. Br J Cancer 2:405–410
Wester RC, Noonan PK, Smeach S, Kosobud L (1983) Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in rhesus monkey: estimate of percutaneous first-pass metabolism. J Pharm Sci 72:745–748
Weston A, Grover PL, Sims P (1982 a) Formation of the 11,12-diol as a metabolite of ben-zo[a]pyrene by rat skin in vivo. Biochem Biophys Res Commun 105:935–941
Weston A, Grover PL, Sims P (1982 b) Metabolism and activation of benzo[a]pyrene by mouse and rat skin in short-term organ culture and in vivo. Chem Biol Interact 42:233–250
Weston A, Grover PL, Sims P (1983 a) Metabolic activation of benzo[a]pyrene in human skin maintained in short-term organ culture. Chem Biol Interact 45:359–371
Weston A, Grover PL, Sims P (1983 b) Formation of the 1,2-diol as a metabolite of 7,12-dimethylbenz[a]anthracene by rodent and human skin. Carcinogenesis 4:1307–1311
Weston A, Hodgson RM, Hewer AJ, Kuroda R, Grover PL (1985) Comparative studies of the metabolic activation of chrysene in rodent and human skin. Chem Biol Interact 54:233–242
Wiebel FJ, Gelboin HV (1977) Cutaneous carcinogenesis: metabolic interaction of chemical carcinogens with skin. In: Lee DHK (ed) Environmental physiology: reactions to environmental agents. Williams and Wilkins, Baltimore, pp 337–348 (Handbook of physiology, sect 9)
Wiebel FJ, Lentz JC, Diamond L, Gelboin HV (1971) Aryl hydrocarbon (benz[a]pyrene) hydroxylase in microsomes from rat tissue: differential inhibition and stimulation by benzoflavones and organic solvents. Arch Biochem Biophys 144:78–86
Wiebel FJ, Leutz JC, Gelboin HV (1973) Aryl hydrocarbon (benzo[a]pyrene) hydroxylase: inducible in extrahepatic tissues of mouse strains not inducible in liver. Arch Biochem Biophys 154:292–294
Wiebel FJ, Leutz JC, Gelboin HV (1975) Aryl hydrocarbon (benzo[a]pyrene) hydroxylase: a mixed-function oxygenase in mouse skin. J Invest Dermatol 64:184–189
Wiegrebe W, Retzow A, Plumier E, Ersoy N, Garbe A, Faro HP, Kunert R (1984) Dermal absorption and metabolism of the antipsoriatic drug dithranol triacetate. Arzneim Forsch 34:48–51
Wislocki PG, Chang RL, Wood AW, Levin W, Yagi H, Hernandez O, Mah HD, Dansette MP, Jerina DM, Conney AH (1977) High carcinogenicity of 2-hydroxybenzo[a]pyrene on mouse skin. Cancer Res 37:2608–2611
Wood AW, Levin W, Chang RL, Lehr RE, Schaefer-Ridder M, Karle JM, Jerina DM, Conney AH (1977) Tumorigenicity of five dihydrodiols of benz[a]anthracene on mouse skin: exceptional activity of benz[a]anthracene 3,4-dihydrodiol. Proc Natl Acad Sci USA 74:3176–3179
Wood AW, Chang RL, Levin W, Ryan DE, Thomas PE, Mah HD, Karle JM, Yagi H, Jerina DM, Conney AH (1979) Mutagenicity and tumorigenicity of phenanthrene and chrysene epoxides and diol epoxides. Cancer Res 39:4069–4077
Yu CD, Fox JL, Ho NFH, Higuchi WI (1979) Physical model evaluation of topical prodrug delivery — simultaneous transport and bioconversion of vidarabine-5′-valerate II: parameter determinations. J Pharm Sci 68:1347–1357
Yu CD, Fox JL, Higuchi WI, Ho NFH (1980 a) Physical model evaluation of topical prodrug delivery — simultaneous transport and bioconversion of vidarabine-5′-valerate IV: distribution of esterase and deaminase enzymes in hairless mouse skin. J Pharm Sci 69:772–775
Yu CD, Gordon NA, Fox JL, Higuchi WI, Ho NFH (1980 b) Physical model evaluation of topical prodrug delivery — simultaneous transport and bioconversion of vidarabine-5′-valerate V: mechanistic analysis of influence of nonhomogeneous enzyme distributions in hairless mouse skin. J Pharm Sci 69:775–780
Yuspa SH, Hennings H, Dermer P, Michael D (1976) Dimethyl sulfoxide-induced enhancement of 7,12-dimethylbenz[a]anthracene metabolism and DNA binding in differenti-tating mouse epidermal cell cultures. Cancer Res 36:947–951
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kappus, H. (1989). Drug Metabolism in the Skin. In: Greaves, M.W., Shuster, S. (eds) Pharmacology of the Skin II. Handbook of Experimental Pharmacology, vol 87 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74054-1_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-74054-1_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74056-5
Online ISBN: 978-3-642-74054-1
eBook Packages: Springer Book Archive